Results 21 to 30 of about 31,114 (261)

Hyperthermic intrathoracic/intraperitoneal chemotherapy versus conventional intrapleural/intraperitoneal chemotherapy for the malignant effusion: a multi-center randomized clinical trial

International Journal of Hyperthermia, 2023
Objective To compare the efficacy and safety of hyperthermic intrathoracic/intraperitoneal chemotherapy versus conventional intrapleural/intraperitoneal chemotherapy in the treatment of malignant pleural or peritoneal effusion.Methods A randomized ...
Lili Liu, Tao Zhang, Xiang Song, Cheng-gong Liao, Tengyun Xu, Yang Yang, Ming Zeng, Junmei Jia, Haichuan Su, Yang Song, Jie Min, Hongmei Zhang, Wei Li, Hongwei Zhang, Helong Zhang   +14 more
doaj   +1 more source

Secondary Cytoreduction and Carboplatin Hyperthermic Intraperitoneal Chemotherapy for Platinum-Sensitive Recurrent Ovarian Cancer: An MSK Team Ovary Phase II Study

Journal of Clinical Oncology, 2021
PURPOSE The purpose of this phase II study was to evaluate hyperthermic intraperitoneal chemotherapy (HIPEC) with carboplatin for recurrent ovarian cancer during secondary cytoreductive surgery.
O. Zivanovic, D. Chi, Qin C Zhou, A. Iasonos, J. Konner, V. Makker, R. Grisham, Amy K Brown, S. Nerenstone, John P Diaz, E. Schroeder, C. Langstraat, V. Paroder, Y. Lakhman, Krysten Soldan, K. Su, G. Gardner, V. Andikyan, Jianxia Guo, E. Jewell, K. L. Long Roche, T. Troso-Sandoval, S. Lichtman, L. Moukarzel, K. Dessources, N. Abu-Rustum, C. Aghajanian, W. Tew, J. Beumer, Y. Sonoda, R. O'Cearbhaill   +30 more
semanticscholar   +1 more source

Pressurized intraperitoneal aerosol chemotherapy (PIPAC) in multimodal therapy for patients with oligometastatic peritoneal gastric cancer: a randomized multicenter phase III trial PIPAC VEROne

Pleura and Peritoneum, 2022
Peritoneal carcinomatosis is the most frequent site of metastases in patients with gastric cancer. Current standard treatment is palliative systemic chemotherapy with very poor prognosis.
Casella Francesco, Bencivenga Maria, Rosati Riccardo, Fumagalli Uberto Romario, Marrelli Daniele, Pacelli Fabio, Macrì Antonio, Donini Annibale, Torroni Lorena, Pavarana Michele, De Manzoni Giovanni   +10 more
doaj   +1 more source

Is cytoreductive surgery and hyperthermic intraperitoneal chemotherapy indicated in hepatobiliary malignancies?

World Journal of Surgical Oncology, 2020
Background Hepatopancreaticobiliary malignancies with peritoneal carcinomatosis exhibit poor survival with current therapies: hepatocellular carcinoma 11 months with sorafenib, and pancreaticobiliary 9–14 months with systemic chemotherapy.
Natasha Leigh, Daniel Solomon, Eric Pletcher, Daniel M. Labow, Deepa R. Magge, Umut Sarpel, Benjamin J. Golas   +6 more
doaj   +1 more source

Gastric cancer: modern approaches and prospects of treatment for peritoneal carcinomatosis (literature review)

Сибирский онкологический журнал, 2022
Gastric cancer (gc) is one of the most common cancers worldwide. The majority of newly diagnosed gastric cancer cases present with distant metastases. Peritoneal carcinomatosis (pc) is the most unfavorable type of progression of primary gc, which occurs ...
V. A. Markovich, S. A. Tuzikov, E. O. Rodionov, N. V. Litvyakov, N. O. Popova, M. M. Tsyganov, L. V. Levonyan, S. V. Miller, D. V. Podolko, I. A. Tsydenova, M. K. Ibragimova   +10 more
doaj   +1 more source

Complications and Mortality Rate of Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy: Italian Peritoneal Surface Malignancies Oncoteam Results Analysis

Cancers, 2022
Simple Summary Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy has been introduced in order to improve outcomes for selected patients with peritoneal surface malignancies.
F. Carboni, M. Valle, M. Vaira, P. Sammartino, O. Federici, M. Robella, M. Deraco, M. Framarini, A. Macrì, C. Sassaroli, P. Lippolis, A. di Giorgio, D. Biacchi, L. Martín-Román, I. Sperduti, D. Baratti   +15 more
semanticscholar   +1 more source

Survival prediction by Bayesian network modeling for pseudomyxoma peritonei after cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy

Cancer Medicine, 2022
To establish a survival prognostic model for pseudomyxoma peritonei (PMP) treated with cytoreductive surgery (CRS) plus hyperthermic intraperitoneal chemotherapy (HIPEC) based on Bayesian network (BN).
Xin Zhao, Xinbao Li, Yulin Lin, R. Ma, Ying Zhang, Dazhao Xu, Yan Li   +6 more
semanticscholar   +1 more source

Primary ovarian high-grade endometrial stromal sarcoma: a case report

Journal of Medical Case Reports, 2021
Background Primary ovarian high-grade endometrial stromal sarcoma is a very rare disease. Even though it has poor prognosis, the gold standard treatment has not been established owing to its rarity.
Ji Sun Lee, Dayong Lee, Jisun Lee, Man-Hoon Han, Dae Gy Hong, Hyun Jung Lee   +5 more
doaj   +1 more source

Cytoreduction and HIPEC in the treatment of "unconventional" secondary peritoneal carcinomatosis [PDF]

, 2015
BACKGROUND: Peritoneal metastasis (PM) is considered a terminal and incurable disease. In the last 30 years, cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) radically changed the therapeutic approach for these patients ...
Accarpio, Fabio, Biacchi, Daniele, Cardi, Maurizio, DI GIORGIO, Angelo, Mingarelli, Valentina, Musio, Daniela, Sammartino, Paolo, Sibio, Simone, Sollazzo, BIANCA MARIA   +8 more
core   +2 more sources

Perioperative Systemic Therapy vs Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Alone for Resectable Colorectal Peritoneal Metastases: A Phase 2 Randomized Clinical Trial.

JAMA Surgery, 2021
Importance To date, no randomized clinical trials have investigated perioperative systemic therapy relative to cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS-HIPEC) alone for resectable colorectal peritoneal metastases (CPM ...
K. Rovers, C. Bakkers, S. Nienhuijs, J. Burger, G. Creemers, A. M. Thijs, A. Brandt-Kerkhof, E. Madsen, E. van Meerten, J. Tuynman, M. Kusters, K. S. Versteeg, A. Aalbers, N. Kok, T. Buffart, M. Wiezer, D. Boerma, M. Los, P. D. de Reuver, A. Bremers, H. Verheul, S. Kruijff, D. D. de Groot, A. Witkamp, W. V. van Grevenstein, M. Koopman, J. Nederend, M. Lahaye, O. Kranenburg, R. Fijneman, Iris van 't Erve, P. Snaebjornsson, P. Hemmer, M. Dijkgraaf, C. Punt, P. Tanis, I. D. de Hingh   +36 more
semanticscholar   +1 more source